Todos os Tutoriais

108 artigos

When the Layers Agree: Reading Stool and Broad Protein Panels Alongside the Genome
Gut & Microbiome
Premium

When the Layers Agree: Reading Stool and Broad Protein Panels Alongside the Genome

A clinical guide to interpreting microbiome and high-plex proteomic reports — what each layer actually measures, how much weight it deserves, and why convergence across independent layers is the only signal strong enough to act on.

TutorialAvançado
9 de set. de 2026 0
Imaging the Longevity Workup: What Calcium Scoring, CCTA, Whole-Body MRI, DEXA and CPET Each Buy — and What Each Costs
Heart Health
Premium

Imaging the Longevity Workup: What Calcium Scoring, CCTA, Whole-Body MRI, DEXA and CPET Each Buy — and What Each Costs

A practical framework for sequencing advanced imaging in preventive practice: why a picture of disease outranks a score that predicts it, where coronary calcium goes blind in younger patients, and how to weigh whole-body MRI's occult cancers against its cascades.

TutorialAvançado
8 de set. de 2026 0
Colapso Fibrinolítico: Abordagem Terapêutica de PAI-1 e SERPINE1 no Envelhecimento Vascular
Heart Health
Premium

Colapso Fibrinolítico: Abordagem Terapêutica de PAI-1 e SERPINE1 no Envelhecimento Vascular

Domine a ciência de ponta da disfunção fibrinolítica — de epigenética do *SERPINE1* e circuitos de retroalimentação da senescência aos inibidores emergentes de PAI-1 e protocolos de precisão para restaurar a capacidade de dissolução de coágulos.

TutorialAvançado
8 de set. de 2026 0
Genotype Sets the Hand, Bloodwork Shows How It Is Being Played: Pairing Genetic Risk With Movable Cardiometabolic Markers
Heart Health
Premium

Genotype Sets the Hand, Bloodwork Shows How It Is Being Played: Pairing Genetic Risk With Movable Cardiometabolic Markers

A clinical guide to interpreting genetic risk alongside blood biomarkers in cardiovascular prevention — why apoB beats LDL-C, where Lp(a) fits, how to catch insulin resistance a decade early, and why a laboratory reference range is not a target.

TutorialAvançado
7 de set. de 2026 0
SNPs and SNP Panels: Reading a Curated Variant Report Without Over-Reading It
Longevity & Aging
Premium

SNPs and SNP Panels: Reading a Curated Variant Report Without Over-Reading It

A clinical guide to what common single-nucleotide variants and curated panels genuinely deliver — pharmacogenomic phenotypes, HLA risk types, polygenic percentiles — and the structural reasons a negative panel in a symptomatic patient tells you almost nothing.

TutorialAvançado
7 de set. de 2026 0
HLA Typing in Practice: The Results That Prevent a Severe Drug Reaction — and the Ones That Only Rule Out Disease
Autoimmune & Arthritis
Premium

HLA Typing in Practice: The Results That Prevent a Severe Drug Reaction — and the Ones That Only Rule Out Disease

A clinical guide to reading HLA results: which alleles change prescribing today, why a coeliac-permissive type is not a diagnosis, and when a genome-derived HLA call must be confirmed before you act on it.

TutorialAvançado
6 de set. de 2026 0
Reading a Pharmacogenomic Report: The Gene–Drug Pairs That Actually Change a Prescription
Longevity & Aging
Premium

Reading a Pharmacogenomic Report: The Gene–Drug Pairs That Actually Change a Prescription

A clinician's guide to interpreting metabolizer phenotype labels, the gene–drug pairs with evidence strong enough to act on today, and why a genotype describes capacity rather than current enzyme activity.

TutorialAvançado
6 de set. de 2026 0
The 94th Percentile Is Not a 94% Risk: Reading Polygenic Scores in Cardiovascular Prevention
Heart Health
Premium

The 94th Percentile Is Not a 94% Risk: Reading Polygenic Scores in Cardiovascular Prevention

A practical guide to interpreting a polygenic risk score report — how the number is built, how to convert a percentile into absolute risk, why the score may not apply to your patient at all, and why a high score usually changes timing and intensity rather than diagnosis.

TutorialAvançado
6 de set. de 2026 0
Pathogenic, Benign, or Uncertain: How a Variant Gets Its Verdict — and What Each Verdict Licenses
Longevity & Aging
Premium

Pathogenic, Benign, or Uncertain: How a Variant Gets Its Verdict — and What Each Verdict Licenses

A clinician's guide to reading the classification column on a genomic report: what dbSNP, gnomAD and ClinVar each contribute, why a variant of uncertain significance must never drive management, and how to explain penetrance to a patient who has just been called 'pathogenic'.

TutorialAvançado
6 de set. de 2026 0
Lactato como Arquiteto Epigenético: Mecanismos Avançados de Longevidade Metabólica
Metabolic Health
Premium

Lactato como Arquiteto Epigenético: Mecanismos Avançados de Longevidade Metabólica

Mergulhe fundo na maquinaria molecular subjacente ao papel do lactato na longevidade — da farmacologia do receptor HCAR1 e estequiometria de lactilação aos circuitos metabólicos inter-órgãos e estratégias de tradução clínica.

TutorialAvançado
6 de set. de 2026 0
From Blood Draw to Variant List: What the Genomic Pipeline Does, and Where It Fails Quietly
Longevity & Aging
Premium

From Blood Draw to Variant List: What the Genomic Pipeline Does, and Where It Fails Quietly

A clinician's guide to the five stages between a sample and a genomic report — what each accomplishes, why millions of variants is a normal result, and how a poorly read region becomes a falsely reassuring negative.

TutorialAvançado
6 de set. de 2026 0
What a 30× Whole Genome Sequence Actually Is — and What It Still Cannot Tell You
Longevity & Aging
Premium

What a 30× Whole Genome Sequence Actually Is — and What It Still Cannot Tell You

A clinical reading guide to 30× whole genome sequencing: what the depth figure means, how it differs from a SNP array and an exome, and the specific variant classes a normal genome report does not exclude.

TutorialAvançado
6 de set. de 2026 0
AnteriorPágina 3 de 9Próximo